Immunic Inc (IMUX) stock has risen 205.57% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives IMUX stock a score of 93 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 98. IMUX's rank also includes a long-term technical score of 91. The fundamental score for IMUX is 88. In addition to the average rating from Wall Street analysts, IMUX stock has a mean target price of 55.625. This means analysts expect the stock to climb 160.05% over the next 12 months.
What's Happening with IMUX Stock Today
Immunic Inc (IMUX) stock has risen 13.72% while the S&P 500 has risen 0.39% as of 11:41 AM on Monday, Nov 23. IMUX has risen $2.58 from the previous closing price of $18.81 on volume of 954,305 shares. Over the past year the S&P 500 is higher by 13.97% while IMUX has risen 205.57%. IMUX lost -$3.14 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Immunic Inc (IMUX) Stock.
